10,350
0.00%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sejahteraraya Anugrahjaya Tbk PT
Its shares trade on IDX under the ticker SRAJ.JK. It has been listed since 11 April 2011. In the fiscal year to 31 December 2025, it reported revenue of IDR 2.59trn and a net loss of IDR 199.00bn. At that date it held total assets of IDR 7.62trn and shareholders' equity of IDR 1.33trn.
PT Sejahteraraya Anugrahjaya Tbk engages in the provision of medical services. The company is headquartered in Tangerang, Banten. The company went IPO on 2011-04-11. The Company’s segments include In-patient, including supporting services, and Out-patient, including supporting services. The firm operates over six hospitals, including Mayapada Hospital Tangerang (MHTG), Mayapada Hospital Jakarta Selatan (MHJS), Mayapada Hospital Kuningan (MHKN), Mayapada Hospital Bogor BMC (MHBG), Mayapada Hospital Surabaya (MHSB) and Mayapada Hospital Bandung (MHBD). The company has a range of centers, which include neuroscience center, uro-nephrology center, cardiovascular center, gastrohepatology, oncology center, orthopedic center, obstetrics and gynecology center, pulmonology and internal medicine, pediatric center, dermato and aesthetic clinic, gastrointestinal and liver center, spine and arthroplasty center, sports injury treatment and performance center, and post-Covid recovery and rehabilitation center.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 11 Apr 2011
- Employees
- 3,437
- Website
- mayapadahospital.com ↗
Leadership
Pay as last reported
- Mr. Jonathan TahirPresident Commissioner
- Ms. Grace Dewi RiadyPresident Director
- Dato' Sri. Prof. Dr. .. TahirVice President Commissioner
- Mr. Charlie SalimDirector (Officer)
- Ms. Victoria TahirDirector (Officer)
- Mr. Arif MualimCompany Secretary, Director
- Dr. H.R. Agung LaksonoCommissioner
- Dr. Daniel TjenCommissioner
- Prof. Dr. Melanie Hendrayati Sadono DjamilIndependent Commissioner
- Dr. Antonius SoedionoIndependent Commissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Over six hospitals including Mayapada Hospital Tangerang and Mayapada Hospital Jakarta Selatan
- 3,437 full-time employees supporting medical services across multiple segments
- Six hospitals with specialized centers like oncology and cardiovascular centers
Weaknesses
- Mayapada Hospital Bogor BMC and Mayapada Hospital Surabaya operate in competitive markets
- Mayapada Hospital Bandung and Mayapada Hospital Kuningan face regional market saturation
- Mayapada Hospital Jakarta Selatan has limited outpatient capacity for high-demand services
Opportunities
- Expanding the neuroscience center to new regions like Bandung and Surabaya
- Increasing the cardiovascular center's services in Jakarta Selatan and Tangerang
- Growing the oncology center through partnerships with international health providers
Threats
- Mayapada Hospital Jakarta Selatan faces rising operational costs in a dense urban area
- Mayapada Hospital Bogor BMC competes with established hospitals in Banten region
- Mayapada Hospital Surabaya must address competition from new medical facilities in East Java
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.